Mandate

Vinge advises Jarðvarmi och Ancala Partners in connection with the acquisition of Magma Energy Sweden AB and HS Orka

June 13, 2019 M&A

Vinge has advised Jarðvarmi slhf., a consortium of 14 Icelandic pension funds, and Ancala Partners’ mid-market focused infrastructure fund Ancala Infrastructure Fund II in questions regarding Swedish law in connection with the acquisition of Magma Energy Sweden AB and its subsidiary HS Orka, Iceland’s largest private electricity generator.

In connection with the transaction, Jarðvarmi exercised its right of first refusal to acquire a 53.9% interest in HS Orka from Alterra Power Corp, a subsidiary of Innergex Renewable Energy Inc. Jarðvarmi has also agreed to acquire a 12.7% interest in HS Orka from Fagfjárfestasjóðurinn ORK. The remaining 33.4% in HS Orka was already owned by Jarðvarmi. Following the transactions Ancala Partners and Jarðvarmi will each own 50% of HS Orka.

The purchase price for the acquisition of Alterra’s 53.9% interest was USD 299.9 million. The purchase price for the acquisition of Fagfjárfestasjóðurinn ORK’s 12.7% interest was not disclosed. 

Ancala Partners and Jarðvarmi have further agreed to divest HS Orka’s 30% interest in the Blue Lagoon, Iceland’s leading tourist attraction, to Blávarmi. The sale transitions HS Orka into a pure play renewable energy platform. HS Orka has been producing renewable energy for 40 years and operates two geothermal powerplants, Svartsengi and Reykjanes, as well as a hydro powerplant at Bláskógabyggð.

The Vinge team consisted of partner Peter Sundgren and associate Christina Odengran. Counsel Maria Schultzberg advised in tax matters. 

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025